Warburg leads PE flow into Indian APIs with Laurus investment
This article was originally published in Scrip
Executive Summary
Niche active pharmaceutical ingredient (API) players in India continue to attract private equity interest - the latest deal involving Warburg Pincus' acquisition of a minority stake in Laurus Labs for about INR5.50bn ($92m).